Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Industry Seeks Attention At Upcoming U.S.-Europe Trade Talks

This article was originally published in The Gray Sheet

Executive Summary

U.S. and EU device trade groups make the case to government officials for addressing device regulatory harmonization as part of planned Transatlantic Trade and Investment Partnership negotiations.

You may also be interested in...



Europe Urges Greater Alignment On U.S. And EU Device Review

The European Commission issued proposals for the next round of Transatlantic Trade and Investment Partnership talks, including support for a common device approval application for Europe and the U.S.

Industry Sees Harmonization Opportunities In High-level U.S.-EU Trade Talks

Official negotiations between the U.S. and EU on the Transatlantic Trade and Investment Partnership trade agreement began last week. Medical device industry associations representing both regions want the harmonization of U.S. and EU device industry regulations to be part of the agreement.

IMDRF Issues Proposed Guidances On Device Auditors, Global UDI System

The International Medical Device Regulators Forum issued proposed guidance documents on monitoring of device auditing organizations, training for auditors and core elements of a global UDI system.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel